Versant Ventures Iii, Llc - Net Worth and Insider Trading

Versant Ventures Iii, Llc Net Worth

The estimated net worth of Versant Ventures Iii, Llc is at least $36 Million dollars as of 2024-11-13. Versant Ventures Iii, Llc is the 10% Owner of Flexion Therapeutics Inc and owns about 3,921,092 shares of Flexion Therapeutics Inc (FLXN) stock worth over $36 Million. Versant Ventures Iii, Llc is also the 10% Owner of OpGen Inc and owns about 26 shares of OpGen Inc (OPGN) stock worth over $36. Details can be seen in Versant Ventures Iii, Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Versant Ventures Iii, Llc has not made any transactions after 2016-06-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Versant Ventures Iii, Llc

To

Versant Ventures Iii, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Versant Ventures Iii, Llc owns 5 companies in total, including Flexion Therapeutics Inc (FLXN) , PhaseRx Inc (PZRXQ) , and OpGen Inc (OPGN) among others .

Click here to see the complete history of Versant Ventures Iii, Llc’s form 4 insider trades.

Insider Ownership Summary of Versant Ventures Iii, Llc

Ticker Comapny Transaction Date Type of Owner
FLXN Flexion Therapeutics Inc 2016-06-08 10 percent owner
PZRXQ PhaseRx Inc 2016-05-23 10 percent owner
OPGN OpGen Inc 2015-05-08 10 percent owner
LIMIT LIMIT 2013-10-29 10 percent owner
LIMIT LIMIT 2023-08-18 10 percent owner

Versant Ventures Iii, Llc Latest Holdings Summary

Versant Ventures Iii, Llc currently owns a total of 2 stocks. Among these stocks, Versant Ventures Iii, Llc owns 3,921,092 shares of Flexion Therapeutics Inc (FLXN) as of June 8, 2016, with a value of $36 Million and a weighting of 100%. Versant Ventures Iii, Llc also owns 26 shares of OpGen Inc (OPGN) as of May 8, 2015, with a value of $36 and a weighting of 0%.

Latest Holdings of Versant Ventures Iii, Llc

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FLXN Flexion Therapeutics Inc 2016-06-08 3,921,092 9.12 35,760,359
OPGN OpGen Inc 2015-05-08 26 1.40 36

Holding Weightings of Versant Ventures Iii, Llc


Versant Ventures Iii, Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Versant Ventures Iii, Llc has made a total of 0 transactions in Flexion Therapeutics Inc (FLXN) over the past 5 years. The most-recent trade in Flexion Therapeutics Inc is the acquisition of 714,285 shares on June 8, 2016, which cost Versant Ventures Iii, Llc around $10 Million.

According to the SEC Form 4 filings, Versant Ventures Iii, Llc has made a total of 0 transactions in OpGen Inc (OPGN) over the past 5 years. The most-recent trade in OpGen Inc is the acquisition of 4 shares on May 8, 2015, which cost Versant Ventures Iii, Llc around $2 Million.

Insider Trading History of Versant Ventures Iii, Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Versant Ventures Iii, Llc Trading Performance

GuruFocus tracks the stock performance after each of Versant Ventures Iii, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Versant Ventures Iii, Llc is -4.9%. GuruFocus also compares Versant Ventures Iii, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Versant Ventures Iii, Llc within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Versant Ventures Iii, Llc's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Versant Ventures Iii, Llc

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 8.88 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 9.49 LIMIT LIMIT LIMIT LIMIT LIMIT

Versant Ventures Iii, Llc Ownership Network

Ownership Network List of Versant Ventures Iii, Llc

No Data

Ownership Network Relation of Versant Ventures Iii, Llc

Insider Network Chart

Versant Ventures Iii, Llc Owned Company Details

What does Flexion Therapeutics Inc do?

Who are the key executives at Flexion Therapeutics Inc?

Versant Ventures Iii, Llc is the 10 percent owner of Flexion Therapeutics Inc. Other key executives at Flexion Therapeutics Inc include Chief Regulatory Officer Kerry Wentworth , Chief Strategy Officer Christina Willwerth , and General Counsel Mark S. Levine .

Flexion Therapeutics Inc (FLXN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Flexion Therapeutics Inc (FLXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Flexion Therapeutics Inc (FLXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Flexion Therapeutics Inc (FLXN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Flexion Therapeutics Inc Insider Transactions

No Available Data

Versant Ventures Iii, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Versant Ventures Iii, Llc. You might contact Versant Ventures Iii, Llc via mailing address: One Sansome Street, Suite 1650, San Francisco Ca 94104.